Biostax Corp (BTAX)

[StockRoomBully]

Once Cytocom merger finalized and listed. $Imun buyout next.. So easy to see. No need to RS. Get in while the getting is good.

Once the Cytocom/Cleveland BioLabs merger is completed, we will have a new company operating under the name “Cytocom, Inc.” that we expect to have listed on the Nasdaq Capital Market if the combined company meets all the Nasdaq listing requirements. We anticipate trading on the Nasdaq Capital Market under the proposed ticker symbol “CYTO.”

Fyi $Imun pathway to uplist right infront out eyes

"In December 2013, the Company formed a new subsidiary, Cytocom Inc., to focus on conducting LDN and MENK clinical trials in the United States. In December 2014, the Company completed the distribution of common stock of Cytocom Inc. to its shareholders.

As part of the transaction, the Company retained exclusive rights to all international patents, in-country approvals, formulations, trademarks, manufacturing, marketing, sales, and distributions rights in emerging nations, including Africa, Central America, South America, Russia, India, China, Far East, and The Commonwealth of Independent States (former Soviet Union).

The Company will continue to have access to existing clinical data as well as any new data generated by Cytocom Inc. during drug development.

On December 8, 2014, the number of Cytocom Inc. shares of common stock that were issued to our shareholders totaled 113,242,522 shares.


In connection with the transaction, Cytocom Inc. issued 140,100,000 shares of its common stock to the Company, which gave the Company a 55.3% stake in Cytocom Inc. on that date.


The stake has since been reduced to 50.2% at December 31, 2015, by subsequent issuances of Cytocom common stock to shareholders."